ADiTx Therapeutics Depreciation & Amortization 2011-2026 | ADTX

Annual Depreciation & Amortization ADiTx Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
614 K	435 K	429 K	369 K	17.8 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
614 K	17.8 K	373 K

Quarterly Depreciation & Amortization ADiTx Therapeutics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
67 K	68.4 K	-	148 K	157 K	143 K	-	110 K	110 K	110 K	-	100 K	99.9 K	96.9 K	-	266 K	100 K	66.2 K	-	2.8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
266 K	2.8 K	110 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	8 M	$ 15.87	-4.08 %	$ 3.78 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.54	-2.62 %	$ 1.06 B	Canada
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aptorum Group Limited APM	1.13 M	$ 0.82	-0.73 %	$ 4.47 M	China
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	1.56 M	$ 20.36	2.49 %	$ 2.57 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	67.7 M	$ 75.13	-1.83 %	$ 1.45 B	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.51	-7.36 %	$ 385 M	Britain
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	503 K	$ 162.19	-1.15 %	$ 8.07 B	USA
BridgeBio Pharma BBIO	5.43 M	$ 64.72	-2.73 %	$ 12.4 B	USA
Brainstorm Cell Therapeutics BCLI	240 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	79.6 M	$ 60.15	-0.46 %	$ 11.5 B	USA
Equillium EQ	126 K	$ 1.7	-3.14 %	$ 59 M	USA
Cabaletta Bio CABA	1.43 M	$ 3.3	-3.89 %	$ 3.85 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	13.6 M	$ 3.02	-5.63 %	$ 1.08 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	1.07 M	$ 25.16	-1.33 %	$ 674 M	USA
Agios Pharmaceuticals AGIO	5.2 M	$ 27.77	-1.49 %	$ 1.61 B	USA